reSee.it Podcast Summary
The episode centers on cryonics, explained by Dr. Max More of Alcor, a nonprofit organization that preserves people after legal death with the aim of possible future revival. Cryonics, the preservation at about minus 320 Fahrenheit, follows the distinction that it is not cryogenics (the engineering of low temperatures) and not simply cryobiology (the study of cold effects). The premise is to keep tissues viable until future technology might repair whatever killed them. Preservation begins at the point of legal death, ideally with the medical team at the bedside, and proceeds through rapid stabilization and careful cooling to maximize viability for revival.
During stabilization, the patient is moved to an ice bath, covered with ice and water, a mechanical CPR device operates, and a respirator takes over breathing. Medications are administered, notably propofol to slow brain metabolism and prevent any return to consciousness, plus anticoagulants and other drugs to prevent clotting and support blood pressure. After stabilization, the patient is perfused: blood and intracellular fluids are drained and replaced with a medical cryoprotectant so tissues remain viable for long-term storage. The goal is to protect neural and other cells during transport to the preservation facility, and to begin the cooling process in a controlled way.
Cooling proceeds in stages, avoiding premature freezing that would damage cells. The body is gradually cooled to just above freezing and then to temperatures compatible with liquid nitrogen. Final storage occurs at minus 196 Celsius (minus 320 Fahrenheit) in vacuum-insulated aluminum vessels. Some members opt for whole-body preservation, others for neuro preservation with the brain kept inside the skull. The process is technically demanding, and revival remains uncertain; major challenges include rewarming without ice recrystallization, which can damage cells. The conversation emphasizes that revival depends on advances in brain repair, organ and tissue regeneration, and, potentially, nanotechnology, rather than any single breakthrough.
A central concept discussed is information-theoretic death: legal and clinical death may occur even when meaningful information persists in the brain, making revival conceivable in principle if enough information remains. The interview notes that future revival likely hinges on breakthroughs such as lab-grown organs, regenerative therapies, and nanoscale machines that could repair tissue and restore function. Alcor frames cryonics as an extension of emergency medicine rather than immortality; it seeks to preserve life for a future era when technology could restore it.
Alcor’s organizational model is nonprofit, funded largely by life insurance. Membership runs around six hundred dollars annually, and the cryopreservation fee for a whole body starts at two hundred thousand dollars, while neuro preservation begins at eighty thousand. Most members use life insurance to fund these costs, and a dedicated patient care fund endows long-term preservation with restrictions on withdrawals. Alcor stores approximately 196 human patients and about 100 pets, mostly in Scottsdale, Arizona, chosen for environmental stability and a history of legal stability after earlier California challenges, including the Dora Kent case in 1988. The facility offers tours, publishes case reports for transparency, and emphasizes patient rights, with public and private storage options. Ted Williams and Hal Finney are noted as prominent public or well-known patients linked to cryonics.
The discussion also covers social and philosophical implications: the possibility of future space-based living communities, the rejuvenation of the body to avoid aging, and the ethical and legal questions surrounding long-term preservation. Practical cautions include planning well in advance, the difficulty of last-minute cases, and the necessity of clear contracts and governance designed for longevity. The guest reflects on the evolving meaning of death, the potential for future technologies to repair or replace tissues, and the idea that cryonics represents a long-term, informed gamble on life, health, and the possibility of returning to a future world.